Pulsed doppler tissue imaging for the assessment of myocardial viability: comparison with 99mtc sestamibi perfusion imaging

Nuclear Medicine Communications

Volumn 23, Issue 12, 2002, Pages 1197-1204

  Minamihaba, O ^a   Takeishi, Y ^a   Hirono, O ^a   Yamauchi, S ^a   Arimoto, T ^a   Fukui, A ^a   Okuyama, M ^a   Nozaki, N ^a   Akiyama, H ^a   Fatema, K ^a   Miyamoto, T ^a   Takahashi, H ^a   Fujiwara, S ^a   Okada, A ^a   Takahashi, K ^a   Kubota, I ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

99mTc MIBI; Doppler tissue imaging; Myocardial viability

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; FEMALE; HEART INFARCTION; HEART PREEJECTION PERIOD; HEART VENTRICULOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MALE; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RADIONUCLIDE VENTRICULOGRAPHY; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 12244268258     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200212000-00008     Document Type: Article

References (23)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
3. Wacker FJTh, Gibbons RJ, Verani MS, et al. Serial quantitative planer technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol 1989; 14: 861-873.
4. Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic Tc-99m hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989; 80: 1277-1286.
5. Berman DS, Kiat H, Van Train KF, Friedman J, Garcia EV, Maddahi J. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. Am J Cardiol 1990; 66: 72E-79E.
6. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium-99m agents. Semin Nucl Med 1991; 21: 173-181.
7. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994; 23: 617-626.
8. Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995; 91: 2556-2565.
9. Oki T, Tabata T, Yamada H, et al. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997; 79: 921-928.
10. Katz WE, Gulati VK, Mahler CM, Gorcsan 3rd J. Quantitative evaluation of the segmental left ventricular response to dobutamine stress by Doppler tissue echocardiography. Am J Cardiol 1997; 79: 1036-1042.
11. Derumeaux G, Ovize M, Loufoua J, et al. Doppler tissue imaging quantitates regional wall motion during myocardial ischemia and reperfusion Circulation 1998; 97: 1970-1977.
12. Nishino M, Tanouchi J, Tanaka K, et al. Dobutamine stress echocardiography at 7.5 mg/kg/min using color tissue Doppler imaging M-mode safely predicts reversible dysfunction early after reperfusion in patients with acute myocardial infarction. Am J Cardiol 1999; 83: 340-344.
13. Jun T, Hirono O, Kubota I, et al. Dobutamine stress echocardiography for the diagnosis of myocardial viability. Jpn Heart J 2000; 41: 435-443.
14. Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med 1996; 37: 1289-1294.
15. Fujiwara S, Takeishi Y, Atsumi H, et al. Prediction of functional recovery in acute myocardial infarction: comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch. J Nucl Cardiol 1998; 5: 119-127.
16. Takeishi Y, Takahashi N, Fujiwara S, Atsumi H, Takahashi K, Tomoike H. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate. J Nucl Med 1998; 39: 582-586.
17. Fujiwara S, Takeishi Y, Tojo T, et al. Fatty acid imaging with I-123-15-(p-iodophenyl)-9-R,S-methylpentadecanoic acid in acute coronary syndrome. J Nucl Med 1999; 40: 1999-2006.
18. 99mTc sestamibi after direct percutaneous transluminal coronary angioplasty in acute myocardial infarction: relationship with wall motion and functional response to dobutamine stimulation. Nucl Med Commun 2001; 22: 1223-1230.
19. Beller GA, Ragosta M, Watson DD, Gimple LW. Myocardial thallium-201 scintigraphy for assessment of viability in patients with severe left ventricular dysfunction. Am J Cardiol 1992; 70: 18E-22E.
20. 201Tl washout after thallium reinjection. Options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection. Circulation 1992; 85: 1032-1038.
21. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1838.
22. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988; 77: 491-498.
23. Dilsizian V, Arrighi JA, Diodati JG, et al. Myocardial viability in patients with chronic coronary artery disease: comparison of Tc-99m sestamibi with thallium reinjection and [F-18]fluorodeoxyglucose. Circulation 1994; 89: 578-587.